The Latest Cardiac and Vascular News
MARLBOROUGH, Mass., June 16, 2020 /PRNewswire/ — CardioFocus, Inc. today announced that the first U.S. patients have been treated commercially with the recently-approved HeartLight® X3 Endoscopic Ablation System. The revolutionary cardiac ablation technology is designed to treat drug refractory, symptomatic paroxysmal atrial fibrillation (AFib), the most common heart rhythm disorder. Henry D. Huang, M.D., FACC, […]
DALLAS, June 16, 2020 /PRNewswire/ — The StopAfib.org Library, an invaluable collection of video resources for people living with atrial fibrillation (afib), is now available at no cost. The world-renowned StopAfib.org patient advocacy organization empowers those living with afib to take control of their treatment and get their lives back. This one-stop source […]
RALEIGH, N.C., June 15, 2020 /PRNewswire/ — Contego Medical, Inc. today announced enrollment of the first patient in the PERFORMANCE II Trial evaluating the safety and effectiveness of the Neuroguard IEP® 3 in 1 Carotid Stent and Post-Dilation Balloon System with Integrated Embolic Protection. The Neuroguard IEP System is designed to treat […]
TAMPA, Fla., June 16, 2020 /PRNewswire/ — Keystone Heart, LTD., a medical device innovator driven to redefine the standard of structural heart care, today announced it has acquired 510 Kardiac Devices, Inc., a privately-held medical device company and makers of the Lim Transseptal System. The Lim Transseptal System was designed to meet the demands […]
CASTLE PINES, Colo., June 16, 2020 /PRNewswire/ — Today Proximo Medical, LLC, a business acceleration solution that addresses medical device commercialization challenges among startup and established medical device technologies looking to expand adoption in the U.S., announced a partnership with Coala Life, a leading Swedish-headquartered digital health company, in select U.S. markets. The COALA® Heart Monitor provides […]
MUMBAI, India, June 16, 2020 /PRNewswire/ — MedAlliance has announced the award of its second CE Mark: SELUTION SLR™ 014 PTCA, a novel Sirolimus Drug Eluting Balloon (DEB), for the treatment of coronary arterial disease. This includes indications for both de-novo lesions as well as in-stent restenosis. The approval applies to a broad […]
DANVERS, Mass.–(BUSINESS WIRE)–Today, Abiomed (NASDAQ: ABMD) launches a cutting-edge digital education platform called CAMP PCI, which stands for Coronary Artery & Myocardial Protected Percutaneous Coronary Intervention, to improve patient outcomes and quality of life with supported high-risk PCI by utilizing best practices, techniques and technologies to enable safer, more effective and complete revascularization. […]
New Software Version for Vantage Orian 1.5T Also Offers Cybersecurity Solutions to Protect Patient Data TUSTIN, Calif.–(BUSINESS WIRE)–Hospitals and institutions are continually looking for ways to improve diagnostic imaging throughput, especially in today’s environment where disinfection of systems and rooms in between patients is crucial. Now, with the newly FDA-cleared […]
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (Nasdaq: ABMD), maker of the Impella heart pump, announced today it has appointed Charles (Chuck) Simonton, M.D., as vice president and chief medical officer. Dr. Simonton is renowned for his leadership in product development and large-scale clinical trials. He was most recently at Abbott Vascular where he served as chief medical officer […]
MONTREAL, June 15, 2020 /PRNewswire/ – Puzzle Medical Devices Inc., (www.puzzlemed.com) announces the closure of its first convertible debenture financing round led by Canadian entrepreneur Pascal Labrecque. Other participants include a United States venture capital firm, entrepreneurs and interventional cardiologists practicing in Canada, the United States and Europe. This investment follows the successful completion of Puzzle Medical’s first preclinical studies […]
